Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents

被引：0
|
作者：
Jean-Marc Barret
Anna Kruczynski
Chantal Etiévant
Bridget T. Hill
机构：
[1] Division de Cancérologie,
[2] Centre de Recherche Pierre Fabre,undefined
[3] 17 avenue Jean Moulin,undefined
[4] 81100 Castres,undefined
[5] France,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2002年 / 49卷
关键词：
F 11782 Combination index Synergy Cultured cells In vivo;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：479 / 486
页数：7
相关论文
共 50 条
  • [1] Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents
    Barret, JM
    Kruczynski, A
    Etiévant, C
    Hill, BT
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (06) : 479 - 486
  • [2] Apoptotic cell death induction by F 11782 a novel dual catalytic inhibitor of topoisomerases I and II
    Etiévant, C
    Kruczynski, A
    Barret, JM
    Perrin, D
    Hill, BT
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (05) : 755 - 763
  • [3] Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases
    A Kruczynski
    C Etiévant
    D Perrin
    T Imbert
    F Colpaert
    B T Hill
    British Journal of Cancer, 2000, 83 : 1516 - 1524
  • [4] Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases
    Kruczynski, A
    Etiévant, C
    Perrin, D
    Imbert, T
    Colpaert, F
    Hill, BT
    BRITISH JOURNAL OF CANCER, 2000, 83 (11) : 1516 - 1524
  • [5] F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action
    Perrin, D
    van Hille, B
    Barret, JM
    Kruczynski, A
    Etiévant, C
    Imbert, T
    Hill, BT
    BIOCHEMICAL PHARMACOLOGY, 2000, 59 (07) : 807 - 819
  • [6] Detection of DNA-strand breaks in cells treated with F 11782, a catalytic inhibitor of topoisomerases I and II
    Barret, JM
    Montaudon, D
    Etiévant, C
    Perrin, D
    Kruczynski, A
    Robert, J
    Hill, BT
    ANTICANCER RESEARCH, 2000, 20 (6B) : 4557 - 4562
  • [7] Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells
    Toshihiko Sunami
    Kazuto Nishio
    Fumihiko Kanzawa
    Kazuya Fukuoka
    Shinzo Kudoh
    Jyunichi Yoshikawa
    Nagahiro Saijo
    Cancer Chemotherapy and Pharmacology, 1999, 43 : 394 - 401
  • [8] Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells
    Sunami, T
    Nishio, K
    Kanzawa, F
    Fukuoka, K
    Kudoh, S
    Yoshikawa, J
    Saijo, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (05) : 394 - 401
  • [9] F 11782 a novel catalytic dual inhibitor of topoisomerases I and II with specific DNA repair inhibitory properties, demonstrating a broad spectrum of antitumour activities in vitro and in vivo.
    Hill, BT
    Barret, JM
    Etievant, C
    Kruczynski, A
    van Hille, B
    Perrin, D
    Imbert, T
    CLINICAL CANCER RESEARCH, 1999, 5 : 3864S - 3864S
  • [10] A dual mechanism of action of the anticancer agent F 11782 on human topoisomerase II α
    Jensen, LH
    Renodon-Cornière, A
    Nitiss, KC
    Hill, BT
    Nitiss, JL
    Jensen, PB
    Sehested, M
    BIOCHEMICAL PHARMACOLOGY, 2003, 66 (04) : 623 - 631
12345